Mannkind reported $50.03M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Adma Biologics ADMA:US $ 32.34M 14.15M
Biodelivery Sciences International BDSI:US $ 77.66M 13.75M
Chemocentryx CCXI:US $ 60.03M 4.65M
Dicerna Pharmaceuticals DRNA:US $ 239.3M 31.64M
Dynavax Technologies DVAX:US $ 528.93M 324.29M
Eli Lilly And LLY:US $ 13682M 1411.2M
Flexion Therapeutics FLXN:US $ 43.99M 4.06M
Halozyme Therapeutics HALO:US $ 113.15M 1.1M
Immunogen IMGN:US $ 111.78M 8.53M
Insmed INSM:US $ 112.5M 12.84M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Karyopharm Therapeutics KPTI:US $ 68.87M 10.74M
Kindred Biosciences KIN:US $ 11.26M 4.71M
Macrogenics MGNX:US $ 68.86M 1.06M
Mannkind MNKD:US $ 50.03M 10.4M
Minerva Neurosciences NERV:US $ 3.08M 1.36M
Novavax NVAX:US $ 1753.42M 101.9M
Novo Nordisk A Fs NVO:US $ 88328M 15530M
Peregrine Pharmaceuticals PPHM:US $ 63.25M 7.69M
Xencor XNCR:US $ 44.32M 1.64M